LOGIN  |  REGISTER
Astria Therapeutics
Amneal Pharmaceuticals

Cigna Issues 2024 Vitality In America Report, Revealing Increased Optimism Among Young Americans and Offering Insights on Workforce Health and Engagement

September 26, 2024 | Last Trade: US$312.32 0.57 -0.18
  • Third annual Vitality In America study shows more people achieving high vitality, driven by improved sense of energy. 
  • While Gen Z adults continue to have the lowest overall vitality, they are feeling more confident, capable, and optimistic.
  • People with high vitality are more than 5X as likely to wake up feeling well-rested, underlining strong link between sleep quality and vitality.
  • Prolonged sitting during the workday is tied to low vitality, with one in 6 workers sitting for more than 8 hours per day.

BLOOMFIELD, Conn., Sept. 26, 2024 /PRNewswire/ -- Although Americans continue to report concerning levels of stress, poor mental health, and loneliness, they are feeling more energized and slightly less likely to report financial insecurity, according to new vitality research from global health company The Cigna Group (NYSE: CI). The third annual Vitality In America report shows a small, but significant 2% shift in people with medium vitality to high vitality – the first sign of improvement since 2022. This year, 1 in 5 people report high vitality, largely due to gains in people feeling energized (up 3% from 2022) and feeling alive and vital (up 4% from 2022).

"Vitality is a measure of overall health and wellbeing and, ultimately, human performance. As a health care company, we are deeply committed to both understanding vitality and helping people, employers, and communities improve it," said David M. Cordani, chairman and CEO of The Cigna Group. "While most of our health care dollars are spent on fixing things after they break, vitality presents an opportunity to look more broadly and identify ways to keep people healthy in the first place. Focusing on vitality offers a sustainable guidepost to make our employment landscape, and our communities, better."

The Vitality In America report is available here. Key findings include:

Gen Z adults still report the lowest levels of vitality but show double-digit improvements in vitality building blocks. Gen Z adults indicate positive changes in their autonomy and competence, which are foundational for vitality. They're steadily acquiring skills for a healthy life, feeling more in control during stressful times, gaining confidence in health goals, and becoming more optimistic since 2022.

The Cigna Group Issues 2024 Vitality In America Report

Sleep quality is highly connected to vitality. Although people report getting the same amount of sleep since 2022, the quality is declining, with 45% waking up feeling rested compared to 53% in 2022. People with high vitality are more than 5x times as likely to say they wake up feeling well-rested.

The Cigna Group Issues 2024 Vitality In America Report

High vitality is linked to higher job satisfaction and better job performance. Workers with high vitality are more engaged and willing to put in extra effort. For example, 86% of high vitality employees are ready to work harder to help their workplace succeed, compared to 43% of low vitality workers.

The Cigna Group Issues 2024 Vitality In America Report

Manager relationships impact worker mental health and vitality. People with high vitality report significantly more positive relationships with their managers. For example, high vitality workers are more than 4x as likely to feel understood by their manager.

The Cigna Group Issues 2024 Vitality In America Report

Prolonged sitting during the workday significantly impacts vitality. Workers who sit for 6+ hours daily have lower vitality, poorer health, and engage in fewer healthy behaviors compared to those who sit less. The lowest vitality workers are the 1 in 6 individuals who are completely sedentary, spending the 8-hour workday sitting down.

The Cigna Group Issues 2024 Vitality In America Report

"These findings offer some actionable insights for both individuals and employers," said Dr. Stuart Lustig, National Medical Executive for Behavioral Health Strategy and Product Design, Cigna Healthcare. "Employers have an opportunity to address workforce vitality by helping employees build and enhance meaningful workplace connections, and managers at every level of an organization can initiate discussions with their team members. Employers can also encourage their colleagues to take full advantage of their health benefits, which often include no-cost mental health care, nutrition and fitness support and can encourage healthier habits."

More insights for employers seeking to improve the vitality of their workforce are available here.

The Vitality In America survey uses the Evernorth Vitality Index to measure an individual's sense of competency, autonomy, and relatedness across eight dimensions of health: emotional, environmental, financial, intellectual, occupational, physical, purpose, and social. Read the report here.

About The Cigna Group

The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services, or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 countries and jurisdictions and has more than 189 million customer relationships around the world. Learn more at thecignagroup.com.

Media Contact:
Jocelyn Parker
(313) 510-4173
This email address is being protected from spambots. You need JavaScript enabled to view it.

Terns Pharmaceuticals

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB